S1E1: Developing a Domestic UK Cannabis Market - Eric Bystrom, CEO of Cellen Therapeutics - Grow Conversations

Alex Fraser, Patient Access Lead at GROW Pharma, speaks to Eric Bystrom, CEO of Cellen Therapeutics, an independent UK based company run by NHS consultants who are on a mission to break down the barriers to accessing medical cannabis. Discussing a range of topics including- Issues with patient access- Developing bespoke medicines|- Nuances of developing cannabis medicines for the UK- Project Twenty21?- Real world evidence vs RCT’sAnd much much more.Find our more about Cellen at www.cellenhealth.comFollow Eric on www.twitter.com/e_bystromFollow Alex on www.twitter.com/AlexFraserCanna -----------------------------------------------------------------------------------------------------Grow Conversations is your window into the world of medical cannabis.Brought to you by Grow Group UK - Unlocking the Medical Potential of CannabisGrow Group's Links: https://growgroup.komi.io/Follow Alex: https://linktr.ee/alexfrasercannaStay tuned for the next episode coming soon!